CARCINOID TUMOUR OF THE LIVER

CARCINOID TUMOUR OF THE LIVER was reported 24 times

CARCINOID TUMOUR OF THE LIVER is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Somatostatin Analog [EPC] 3 0.0004
1 mu-Opioid Receptor Agonist [EPC] 1 0.0003
2 GLP-2 Analog [EPC] 1 0.0001
3 Rifamycin Antibacterial [EPC] 1 0.0000
4 Tetracycline-class Drug [EPC] 1 0.0000
5 Integrin Receptor Antagonist [EPC] 1 0.0000
6 Factor Xa Inhibitor [EPC] 3 0.0000
7 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1 0.0000
8 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
9 Aldosterone Antagonist [EPC] 1 0.0000
10 Janus Kinase Inhibitor [EPC] 1 0.0000
11 Kinase Inhibitor [EPC] 3 0.0000
12 Interferon beta [EPC] 1 0.0000
13 Platinum-based Drug [EPC] 1 0.0000
14 beta-Adrenergic Blocker [EPC] 1 0.0000
15 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
16 Vitamin C [EPC] 1 0.0000
17 Loop Diuretic [EPC] 1 0.0000